The University of Tennessee Health Science Center is a public medical school in Memphis, Tennessee. It includes the Colleges of Health Professions, Dentistry, Graduate Health Sciences, Medicine, Nursing, and Pharmacy.

During the past decade, University of Tennessee Health Sciences Center, Dept. of Neurology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Tennessee Health Sciences Center, Dept. of Neurology" are "Epilepsy" (1 trials) and "Refractory Partial Onset Seizures" (1 trials). Many other conditions were trialed in "University of Tennessee Health Sciences Center, Dept. of Neurology" in a lesser frequency.

Most popular intervention types in "University of Tennessee Health Sciences Center, Dept. of Neurology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Rufinamide" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Tennessee Health Sciences Center, Dept. of Neurology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Tennessee Health Sciences Center, Dept. of Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Tennessee Health Sciences Center, Dept. of Neurology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Tennessee Health Sciences Center, Dept. of Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".